Genetic testing indicated multiple tumor-specific mutations including whole-chromosome losses (3, 6, 10, 11, 13, 14, 17, 18, 21, and X) and point mutations inTP53,NF1, andPTEN.Germline mutation testing was within normal limits, including normalTSC1/TSC2. This evidence concerns the gene TSC2 and neoplasm.